#EsoGuard test spotted in today's MedPage Today News and commentary from the world of gastroenterology and hepatology: https://xmrrwallet.com/cmx.plnkd.in/g2C5ajHe
Lucid Diagnostics
Medical Equipment Manufacturing
New York, NY 7,734 followers
Lucid Diagnostics is an esophageal cancer prevention medical diagnostics company. Nasdaq: LUCD
About us
Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, is the first and only commercially available diagnostic test capable of serving as a widespread screening tool to prevent cancer and cancer deaths through early detection of esophageal precancer in at-risk GERD patients. EsoGuard is commercialized in the U.S. as a Laboratory Developed Test (LDT). EsoCheck is commercialized in the U.S. as a 510(k)-cleared esophageal cell collection device.
- Website
-
http://xmrrwallet.com/cmx.pwww.LucidDx.com
External link for Lucid Diagnostics
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Public Company
- Founded
- 2018
Locations
-
Primary
360 Madison Ave
Floor 25
New York, NY 10017, US
Employees at Lucid Diagnostics
-
Jim Fricchione
ESOPHAGEAL CANCER IS PREVENTABLE
-
Joe Erfort
-
Suman Verma
Chief Scientific Officer (CSO), Lucid Diagnostics (Nasdaq: LUCD), VP of Molecular Diagnostics, PAVmed Inc. (Nasdaq: PAVM)
-
Shaun O'Neil
President & Chief Operating Officer at Lucid Diagnostics | (Nasdaq: LUCD) and EVP & Chief Operating Officer at PAVmed Inc. | (Nasdaq: PAVM)
Updates
-
Wondering what it’s like to bring a #CheckYourFoodTube precancer screening event to your department? Hear from a chief who’s already made it happen: "As the Chief of the Chattanooga Fire Department, I would tell any fire chief, fire department, or fire station that Lucid Diagnostics made this whole process easy for the firefighters who attended. Not only were the staff friendly and organized, but they generally cared about the well-being of the firefighters. Precancer screenings for firefighters can be quite intimidating. However, the staff puts firefighters' minds at ease with education and compassion while also throwing in some humor for a group of individuals who like to cut up. The staff also worked patiently with members struggling with the test itself." - Philip Hyman, Fire Chief, Chattanooga Fire Department #EarlyDetectionSavesLives
-
Join us for a business update on August 13, 2025. Details here: https://xmrrwallet.com/cmx.plnkd.in/gwK-TXpN
-
-
Most people think heartburn is just a nuisance. Dr. Steve Schwaitzberg knows better. At UBMD Surgery, he's leading the charge with EsoGuard—a non-invasive DNA test that can detect esophageal precancer before it turns into cancer. See the full story here: https://xmrrwallet.com/cmx.plnkd.in/gm6MJexP #EarlyDetectionSavesLives
-
Fullerton Fire Department partners with Providence St. Jude Medical Center to offer esophageal screenings with the EsoGuard test, amid rising cancer rates and recent wildfire exposures. See the news story here: https://xmrrwallet.com/cmx.plnkd.in/gXSRpdKW
-
"We are grateful to the MolDX team for their rigorous evaluation of our clinical evidence package, which has culminated in this CAC meeting where medical experts will contribute deep domain expertise and real-world experience in nonendoscopic esophageal precancer testing," said Lishan Aklog, MD Lucid Diagnostics Chairman and CEO. Read today's news here: https://xmrrwallet.com/cmx.plnkd.in/gsi3rdR7
-
-
Esophageal cancer is one of the deadliest—but it doesn’t have to be. See how EsoGuard, a quick, non-invasive test, helped Dr. Panzarella detect Patricio's precancer early—before it became cancer. Watch the full story here: https://xmrrwallet.com/cmx.plnkd.in/gxtpmJc6
-
Esophageal cancer is linked to very common symptoms that are often ignored. A recent New York Post article highlights what a gut doctor says you shouldn’t overlook. Early detection can save lives— #CheckYourFoodTube https://xmrrwallet.com/cmx.plnkd.in/e5KsQNYW
-
“Digestive cancers, especially esophageal cancer, are among the deadliest, yet gastrointestinal esophageal reflux disease (GERD) is a common, treatable precursor,” Dr. Kenneth Chang said. “This makes esophageal cancer highly preventable. With the right strategy and implementation, we could make Orange County an esophageal cancer-free zone.” Read the USA TODAY Hoag Health System story: https://xmrrwallet.com/cmx.plnkd.in/g36tnA4N
-
Dan Reilly was living a healthy, active life when chest pain and trouble swallowing revealed a mass in his esophagus—stage 3 esophageal adenocarcinoma. Dan turned his battle into a mission of hope. In his book Seize Your Second Chance, he shares how cancer reshaped his perspective, his purpose, and his passion for helping others. Today, he is a powerful advocate for early esophageal cancer screening and awareness. “For anyone still fighting, holding on to hope, or supporting a loved one through this journey—you are not alone. Miracles happen, and second chances are real.” You can find Dan's book here: https://xmrrwallet.com/cmx.plnkd.in/gmTXfSPw Here’s to strength, resilience, and second chances. 💙#CancerSurvivorsMonth #SurvivorStories #PatientPerspective